Dr Abdelilah Arredouani

Dr. Abdelilah Arredouani obtained a Masters degree in biotechnology management, option molecular biology, and a Ph.D. in biomedical sciences, option cell physiology, both from Belgium. He then worked in the Netherlands at the Erasmus Medical Center in Rotterdam, in the UK at Oxford University, and in Qatar at Cornell Medical College. He is currently a scientist at Qatar Biomedical Research Institute (QBRI) and assistant professor at Hamad Bin Khalifa University. His research focuses mainly on identifying new biomarkers for early diagnosis and prediction of prediabetes and type 2 diabetes. He is also interested in understanding the mechanisms that underly the benificial effect of the glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver. He has published in high impact peer-reviewed journals, including diabetes, nature chemical biology, nature, current biology, JBC, Journal of translational medicine, and scientific reports.